REPURCHASE OF SHARES IN ASTRAZENECA PLC

 

Further to the announcement of its irrevocable, non-discretionary share repurchase programme for the period 20 December 2011 to 2 February 2012, AstraZeneca PLC announced that under the terms of that programme it purchased for cancellation 463,410 ordinary shares of AstraZeneca PLC at a price of 3090 pence per share on 17 January 2012. Upon the cancellation of these shares, the number of shares in issue will be 1,287,735,174.

A C N Kemp

Company Secretary

18 January 2012


 

 

AstraZeneca

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialisation of prescription medicines. As a leader in gastrointestinal, cardiovascular, ...

View more


  CONTACT  
  • Anna Carbin-Åhlund - Press Contact
  • +468-553 269 39
  •  
 
 
 
 
Social Media Pitch:
REPURCHASE OF SHARES IN ASTRAZENECA PLC http://bit.se/Ficndn